Strategies to increase nitric oxide signalling in cardiovascular disease
JO Lundberg, MT Gladwin, E Weitzberg - Nature reviews Drug …, 2015 - nature.com
Nitric oxide (NO) is a key signalling molecule in the cardiovascular, immune and central
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …
Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials
AS Antonopoulos, M Margaritis, R Lee… - Current …, 2012 - ingentaconnect.com
Ample evidence exists in support of the potent anti-inflammatory properties of statins. In cell
studies and animal models statins exert beneficial cardiovascular effects. By inhibiting …
studies and animal models statins exert beneficial cardiovascular effects. By inhibiting …
Endothelial dysfunction due to eNOS uncoupling: Molecular mechanisms as potential therapeutic targets
A Janaszak-Jasiecka, A Płoska, JM Wierońska… - Cellular & molecular …, 2023 - Springer
Nitric oxide (NO) is one of the most important molecules released by endothelial cells, and
its antiatherogenic properties support cardiovascular homeostasis. Diminished NO …
its antiatherogenic properties support cardiovascular homeostasis. Diminished NO …
Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases
Nitric oxide (NO) is generated endogenously by NO synthases to regulate a number of
physiological processes including cardiovascular and metabolic functions. A decrease in the …
physiological processes including cardiovascular and metabolic functions. A decrease in the …
Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease
The endothelium is the orchestral conductor of blood vessel function. Pathological blood
vessel formation (a process termed pathological angiogenesis) or the inability of endothelial …
vessel formation (a process termed pathological angiogenesis) or the inability of endothelial …
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
C Serban, A Sahebkar, S Ursoniu, DP Mikhailidis… - Scientific reports, 2015 - nature.com
The impact of statin therapy on plasma asymmetric dimethylarginine (ADMA) levels has not
been conclusively studied. Therefore the aim of the meta-analysis was to assess the effect of …
been conclusively studied. Therefore the aim of the meta-analysis was to assess the effect of …
Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms
Chronic inflammation enhances the detrimental role of dyslipidaemia during atherogenesis.
Statins are among the most effective anti-atherosclerotic medications, being able to impact …
Statins are among the most effective anti-atherosclerotic medications, being able to impact …
Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) enzymes as an emerging therapeutic strategy to target angiogenesis and vasculogenic mimicry in …
JA Hulin, EA Gubareva, N Jarzebska… - Frontiers in …, 2020 - frontiersin.org
The small free radical gas nitric oxide (NO) plays a key role in various physiological and
pathological processes through enhancement of endothelial cell survival and proliferation …
pathological processes through enhancement of endothelial cell survival and proliferation …
MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic …
L Zhang, D Huang, Q Wang, D Shen, Y Wang… - … drugs and therapy, 2014 - Springer
Purpose Inflammation participates centrally in all stages of atherosclerosis (AS), which
begins with pro-inflammatory processes and inflammatory changes in the endothelium …
begins with pro-inflammatory processes and inflammatory changes in the endothelium …
Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?
Airway remodeling in asthma contributes to airway hyperreactivity, loss of lung function, and
persistent symptoms. Current therapies do not adequately treat the structural airway …
persistent symptoms. Current therapies do not adequately treat the structural airway …